Rothschild Investment LLC Purchases 79 Shares of Agilent Technologies, Inc. (NYSE:A)

Rothschild Investment LLC boosted its position in Agilent Technologies, Inc. (NYSE:A) by 19.2% in the fourth quarter, HoldingsChannel reports. The firm owned 491 shares of the medical research company’s stock after buying an additional 79 shares during the quarter. Rothschild Investment LLC’s holdings in Agilent Technologies were worth $66,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. CKW Financial Group boosted its stake in Agilent Technologies by 114.9% in the fourth quarter. CKW Financial Group now owns 187 shares of the medical research company’s stock valued at $25,000 after acquiring an additional 100 shares during the last quarter. Global X Japan Co. Ltd. boosted its stake in Agilent Technologies by 161.1% in the fourth quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company’s stock valued at $25,000 after acquiring an additional 116 shares during the last quarter. Ashton Thomas Securities LLC purchased a new position in Agilent Technologies in the third quarter valued at about $31,000. Fortitude Family Office LLC boosted its stake in Agilent Technologies by 68.3% in the third quarter. Fortitude Family Office LLC now owns 234 shares of the medical research company’s stock valued at $35,000 after acquiring an additional 95 shares during the last quarter. Finally, Hanson & Doremus Investment Management boosted its stake in Agilent Technologies by 66.5% in the fourth quarter. Hanson & Doremus Investment Management now owns 263 shares of the medical research company’s stock valued at $35,000 after acquiring an additional 105 shares during the last quarter.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on the stock. Bank of America dropped their target price on shares of Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating on the stock in a research note on Friday, December 13th. Sanford C. Bernstein dropped their target price on shares of Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating on the stock in a research note on Tuesday, November 26th. JPMorgan Chase & Co. dropped their price target on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a research note on Tuesday, November 26th. Wells Fargo & Company dropped their price target on shares of Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating on the stock in a research note on Monday, December 9th. Finally, StockNews.com upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Tuesday, December 24th. Seven analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. According to MarketBeat, Agilent Technologies has an average rating of “Moderate Buy” and a consensus target price of $144.38.

Insiders Place Their Bets

In other news, CEO Padraig Mcdonnell sold 1,911 shares of the stock in a transaction on Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total value of $286,650.00. Following the transaction, the chief executive officer now owns 39,652 shares of the company’s stock, valued at $5,947,800. This represents a 4.60 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Agilent Technologies Stock Performance

NYSE A opened at $134.51 on Thursday. Agilent Technologies, Inc. has a 1 year low of $124.16 and a 1 year high of $155.35. The company has a debt-to-equity ratio of 0.57, a current ratio of 2.09 and a quick ratio of 1.58. The stock has a market capitalization of $38.37 billion, a PE ratio of 30.43, a P/E/G ratio of 3.66 and a beta of 1.07. The company’s 50 day simple moving average is $140.90 and its two-hundred day simple moving average is $139.28.

Agilent Technologies (NYSE:A) last posted its earnings results on Wednesday, February 26th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.27 by $0.04. Agilent Technologies had a net margin of 19.80% and a return on equity of 25.43%. The business had revenue of $1.68 billion for the quarter, compared to analysts’ expectations of $1.67 billion. Analysts predict that Agilent Technologies, Inc. will post 5.56 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 23rd. Shareholders of record on Tuesday, April 1st will be paid a $0.248 dividend. This represents a $0.99 annualized dividend and a yield of 0.74%. The ex-dividend date is Tuesday, April 1st. Agilent Technologies’s dividend payout ratio is presently 22.40%.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.